About this trial
Multiple sclerosis (MS) is an autoimmune disease where immune cells attack the body, triggering an inflammatory response. A study comparing multifield FES and conventional FES on upper extremity motor skills and functional independence in MS patients will be conducted. Results suggest that both types of FES treatments normalize muscle tone, showing superior results compared to those without FES therapy. The study aims to compare the effects of both types on MS patients.
Eligibility criteria
Qualifiers
Be of legal age and sign the informed consent form.
Not suffer from any pathology in the upper limb such as tendinitis, oedema, fractures, etc.
Intact skin (no breaks, scratches, cuts, and other superficial or deep injuries) on the arm where the devices will be placed if applicable
Disqualifiers
Severe medical problems.
Use of a pacemaker.
Pregnancy.
Cutaneous neuropathies.
Trial design
Treatments tested in this trial
- Fesia Grasp
- GLOBUS ELITE